Zymeworks's market cap is currently ―. The company's EPS TTM is $-1.736; its P/E ratio is -5.93; Zymeworks is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 16.93M	$ 16.51M	$ 7.00M	$ 35.58M	$ 402.49M
Gross Profit	$ 16.93M	$ 16.51M	$ 7.00M	$ 35.58M	-
EBIT	$ -19.20M	$ -27.58M	$ -49.50M	$ -22.96M	$ 319.35M
EBITDA	$ -15.86M	$ -21.04M	$ -44.98M	$ -20.06M	$ 321.66M
Net Income Common Stockholders	$ -14.48M	$ -28.69M	$ -51.15M	$ -24.35M	$ 309.20M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 374.33M	$ 295.41M	$ 340.09M	$ 340.79M	$ 492.23M
Total Assets	$ 580.88M	$ 556.37M	$ 602.05M	$ 600.74M	$ 648.73M
Total Debt	$ 26.63M	$ 26.25M	$ 27.13M	$ 27.22M	$ 28.11M
Net Debt	$ -347.70M	$ -269.16M	$ -312.96M	$ -313.57M	$ -464.12M
Total Liabilities	$ 116.07M	$ 132.02M	$ 153.13M	$ 127.20M	$ 155.77M
Stockholders Equity	$ 464.81M	$ 424.34M	$ 448.92M	$ 473.54M	$ 492.96M
Cash Flow	-
Free Cash Flow	$ 12.20M	$ -43.80M	$ -7.20M	$ -84.08M	$ 326.48M
Operating Cash Flow	$ 13.95M	$ -42.67M	$ -6.40M	$ -83.69M	$ 327.36M
Investing Cash Flow	$ -1.34M	$ -7.02M	$ -60.67M	$ -137.72M	$ -22.07M
Financing Cash Flow	$ 50.61M	$ 1.90M	$ 27.60M	$ 1.74M	$ -377.00K

Currency in USD

Zymeworks Earnings and Revenue History

Income Statement >

Zymeworks Debt to Assets

Balance Sheet >

Zymeworks Cash Flow

Cash Flow >

Zymeworks Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing